FDA DEVICE FACTS
Avive Automated External Defibrillator (AED) System
Avive Solutions, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Avive Automated External Defibrillator (AED) is intended for emergency treatment of individuals who are exhibiting symptoms of cardiac arrest. A person in cardiac arrest is unresponsive and is not breathing normally. The Avive AED analyzes the patient's electrocardiogram, interprets the cardiac rhythm, and automatically delivers an electrical shock to treat ventricular fibrillation or pulseless ventricular tachycardia. The Avive AED is indicated for adult and pediatric patients over 1 years of age. When a patient is less than 8 years old, or weighs less than 55 lbs., the Avive AED should be used in Child Mode. Otherwise, the Avive AED should be used in Adult Mode. Therapy should not be delayed in order to determine exact age and/or weight. Avive defibrillators should not be used if the patient is responsive or conscious.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。